Fundraising Fox

Newronika

2 known investors

newronika.com ↗

Newronika develops αDBS, an adaptive deep brain stimulation platform that continuously monitors brain signals and automatically adjusts stimulation in real time for patients with Parkinson's disease. The system combines sensing hardware, a patented proportional control algorithm, and cloud-based data intelligence to keep patients within their therapeutic window and reduce side effects.

AI & Machine LearningDigital HealthMedical Devices

Investors · 2

Indaco Venture PartnersMilan
Innogest CapitalreportedMilan

In the news

Newronika closes €13.6 million funding round following US FDA approval for adaptive DBS trialneuronewsinternational.com · Feb 2025Italy’s Newronika raises €13.6M to build brain computerssiliconcanals.com · Feb 2025Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platformprnewswire.com · Feb 2025Newronika Gains €13.6M Series B Funding for Parkinson’s Treatmenttechnews180.com · Feb 2025Newronika Raises an 8.4M EUR Series-A Roundprnewswire.com · Sep 2019Neuromodulation Therapy Developer Newronika Raises €1.7M in Venture Capital - FinSMEsfinsmes.com · Jun 2016

Frequently asked questions

What does Newronika do?
Newronika develops αDBS, an adaptive deep brain stimulation platform that continuously monitors brain signals and automatically adjusts stimulation in real time for patients with Parkinson's disease. The system combines sensing hardware, a patented proportional control algorithm, and cloud-based data intelligence to keep patients within their therapeutic window and reduce side effects.
Who are Newronika's investors?
Newronika's investors include Indaco Venture Partners, Innogest Capital.